Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Aug 8:27:101678.
doi: 10.1016/j.ajoc.2022.101678. eCollection 2022 Sep.

Cyst-like recurrence of retinoblastoma diagnosed by multimodal imaging

Affiliations
Case Reports

Cyst-like recurrence of retinoblastoma diagnosed by multimodal imaging

Noy Ashkenazy et al. Am J Ophthalmol Case Rep. .

Abstract

Purpose: To illustrate the diagnosis and management of an atypical, cyst-like recurrence of retinoblastoma.

Observations: A 4-month-old boy was diagnosed with Group B retinoblastoma in the right eye, consisting of a 10 x 9 × 3.6 mm retinal tumor temporal to the macula. He was treated with one session of intra-arterial ophthalmic artery chemotherapy using melphalan, followed by three sessions of diode laser transpupillary thermotherapy (TTT), after which complete tumor regression was achieved. 45 weeks after initial treatment, a cystic lesion was detected adjacent to superior margin of the regressed tumor scar. The differential diagnosis included pigment epithelial detachment, retinal gliosis, secondary retinoschisis, and local tumor recurrence. Multimodal imaging including OCT angiography confirmed the diagnosis of local recurrence manifesting as a vascularized cyst-like lesion. Two additional sessions of TTT achieved sustained tumor regression through 16 months of additional follow-up.

Conclusions and importance: Recurrence of retinoblastoma following chemotherapy typically manifests as enlargement of a previously regressed tumor, or seeding into the vitreous or subretinal space. An unusual cyst-like recurrence of retinoblastoma at the margin of a previously regressed tumor was diagnosed by multimodal imaging. Focal diode laser transpupillary thermotherapy was curative.

Keywords: Fluorescein angiography; Intra-arterial chemotherapy; Optical coherence tomography; Retinoblastoma; Transpupillary thermotherapy.

PubMed Disclaimer

Conflict of interest statement

None of the authors have any financial disclosures relating to the content of this article.

Figures

Fig. 1
Fig. 1
Initial presentation of unilateral retinoblastoma. A. At presentation, fundus photography (RetCam, Clarity Medical Systems) showed a white vascularized retinal tumor in the temporal macula. B. At presentation, B-scan ultrasonography (Aviso, Quantel Medical) revealed an elevated retinal tumor measuring 10 x 9 × 3.6 mm with intralesional calcifications and intrinsic vascularity. C. At 21 weeks after one session of intra-arterial chemotherapy with melphalan, followed by three sessions of diode laser transpupillary thermotherapy, the tumor was markedly regressed. D. Ultrasonography at that time demonstrated a plaque-like calcified tumor remnant with no evidence of residual viable tumor.
Fig. 2
Fig. 2
Multimodal imaging of cyst-like tumor recurrence. A. At 45 weeks after initial treatment, a cyst-like retinal lesion (arrows) was identified at the superior edge of the regressed primary tumor. B. Fluorescein angiography demonstrated abnormal vascularity and leakage within the cystic lesion, which appeared arise from a vascularized remnant at the nasal edge of the original tumor. C. Optical coherence tomography (OCT) (Spectralis, Heidelberg Engineering, Germany) showed that the cyst-like lesion consisted of an irregularly thickened floor and dome-shaped roof, with effacement of the normal retinal layers. D. OCT angiography (OCTA) demonstrated that the abnormal blood vessels were located mostly within the roof of the lesion within the superficial vascular complex.

References

    1. Harbour J.W. Molecular basis of low-penetrance retinoblastoma. Arch Ophthalmol. 2001;119(11):1699–1704. - PubMed
    1. Michaels S.T., Abruzzo T.A., Augsburger J.J., Corrêa Z.M., Lane A., Geller J.I. Selective ophthalmic artery infusion chemotherapy for advanced intraocular retinoblastoma: CCHMC early experience. J Pediatr Hematol Oncol. 2016;38(1):65–69. - PubMed
    1. Ghassemi F., Khodabande A. Risk definition and management strategies in retinoblastoma: current perspectives. Clin Ophthalmol. 2015;9:985–994. - PMC - PubMed
    1. Berry J.L., Kogachi K., Murphree L., et al. A review of recurrent retinoblastoma: children's hospital los angeles classification and treatment guidelines. Int Ophthalmol Clin. 2019;59(2):65–75. - PMC - PubMed
    1. Abramson D.H., Dunkel I.J., Brodie S.E., et al. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma. Ophthalmology. 2008;115:1398–1404. - PubMed

Publication types

LinkOut - more resources